All lobbying clients
EMERGENT BIOSOLUTIONS INC.
Lobbying client · District of Columbia · filed 2025 to 2026
Biopharmaceutical Company
$5,225,000
Reported spend
32
Filings counted
4
Outside firms hired
6
Bills named
Who filed for this client
5
- EMERGENT BIOSOLUTIONS INC. $4,010,000
- CGCN GROUP, LLC $400,000
- CAPITOL COUNSEL LLC $350,000
- THE NICKLES GROUP, LLC $265,000
- ALPINE GROUP PARTNERS, LLC. $200,000
Reported by year
2 years
- 2026 $2,145,000
- 2025 $3,080,000
Issues lobbied
6
Agencies and chambers lobbied
6
- HOUSE OF REPRESENTATIVES
- SENATE
- Health & Human Services, Dept of (HHS)
- White House Office
- Office of Management & Budget (OMB)
- Office of Natl Drug Control Policy (NDCP)
Recent filings
32 total
Q3 report
View →
Q3 termination
View →
Q3 report
View →
Q3 report
View →
Q2 report
View →
Q2 report
View →
Q2 report
View →
Q2 report
View →
Q1 report
View →
Q1 report
View →
Q1 report
View →
Q1 report
View →
Q4 report
View →
Q4 report
View →
Q4 report
View →
Q4 termination
View →
Q4 report
View →
Q3 report
View →
Q3 report
View →
Q3 report
View →
CGCN GROUP, LLC
THE NICKLES GROUP, LLC
CAPITOL COUNSEL LLC
EMERGENT BIOSOLUTIONS INC.
CGCN GROUP, LLC
THE NICKLES GROUP, LLC
EMERGENT BIOSOLUTIONS INC.
CAPITOL COUNSEL LLC
CGCN GROUP, LLC
CAPITOL COUNSEL LLC
THE NICKLES GROUP, LLC
EMERGENT BIOSOLUTIONS INC.
CGCN GROUP, LLC
THE NICKLES GROUP, LLC
CAPITOL COUNSEL LLC
ALPINE GROUP PARTNERS, LLC.
EMERGENT BIOSOLUTIONS INC.
THE NICKLES GROUP, LLC
CGCN GROUP, LLC
ALPINE GROUP PARTNERS, LLC.